There is growing appetite in Silicon Valley for the legally murky and morally frowned upon practice of embryo-editing. This is how it would work: Companies would use existing gene-editing technology ...
In morning trade on Monday, the health imaging technology company's shares are up 3% to $256.18. This compares favourably to ...
A vote of no confidence in Stormont’s health minister by GPs is a “cry” to Mike Nesbitt to resume negotiations on funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback